Report: Cancer Fonden (Sweden): Difference between revisions
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
'''Access to information:''' [https://static-files.cancerfonden.se/CFrapport-vard-2021.pdf Click here to access]. | '''Access to information:''' [https://static-files.cancerfonden.se/CFrapport-vard-2021.pdf Click here to access]. | ||
{{Lobular}} | |||
{{Breast}} | |||
{{Nipple}} | |||
{{Areola}} | |||
{{Ductal}} | |||
{{Vulva}} | |||
{{Vagina}} | |||
{{Cervix}} | |||
{{Uterus}} | |||
{{Ovary}} | |||
{{Fallopian tubes}} | |||
{{Endometrium}} | |||
{{Esophagus}} | |||
{{Stomach}} | |||
{{Small intestine}} | |||
{{Large intestine}} | |||
{{Rectum}} | |||
{{Anus}} | |||
{{Liver}} | |||
{{Gallbladder}} | |||
{{Bile ducts}} | |||
{{Pancreas}} | |||
{{Colon}} | |||
Revision as of 13:42, 12 September 2024
Go back to Sweden page
Primary purpose: To collaborate with healthcare organizations to map and evaluate methods for increasing participation in cancer screening programs.
Sponsor, manager or home institution: Cancer Fonden.
Type of information: Participation in the national screening; New cases of cervical, breast and colon cancer; Participation cancer screenings; Municipalities with the highest and lowest participation in cancer screenings; cancer incidence, income differences and participation in cancer screenings. Click here to learn more.
Data level: regional level and national level.
Cancer areas of interest: C50: Breast cancer, C51-C58: Female genitalia cancer, and C15-C26: Digestive system cancers. Click here to learn more.
Access to information: Click here to access.
